Temperature sensitive reassortant viruses and a vaccine against equine influenza
AssigneeCornell Research Foundation, Inc.
InventorsLeroy Coggins, Brian R. Murphy, Dorothy F. Holmes, Lynne J. Anguish, James H. Gillespie
Life of this patent
Estimating the term…
Abstract
This invention relates to a method and resulting temperature-sensitive (ts) reassortant virus produced by modifying wild-type equine influenza viruses by utilizing mutagenized human influenza viruses possessing ts lesions and shut off temperatures in the area of 37.degree.-39.degree. C., preferably 37.degree.-38.degree. C. When utilized as a vaccine for equines, these temperature-sensitive recombinant viruses have the facility to develop only mild symptoms while producing protection against infectious equine influenzal disease.
Claims9
A temperature-sensitive virus capable of providing an equine influenza vaccine which is a reassortant mutant virus, formed by mating a wild-type equine influenza virus of the A.sub.1 or A.sub.2 subgroups with chemically mutagenized and temperature-sensitive human influenza virus having a shut off temperature in the area of 37.degree. C. to 39.degree. C., said reassortant virus having at least one temperature-sensitive gene and at least two but no more than six human influenza virus derived genes, and being further characterized as having the serotype of the equine influenza virus and the temperature-sensitive defects of the human virus.
A temperature-sensitive virus capable of providing an equine influenza vaccine which is a reassortant mutant virus, formed by mating a wild-type equine influenza virus of the A.sub.1 or A.sub.2 subgroups with chemically mutagenized and temperature-sensitive human influenza virus having a shut off temperature between 37.degree. C. and 39.degree. C., said reassortant virus having at least one temperature-sensitive gene and at least two but no more than six human influenza virus derived genes and being further characterized as having the serotype of the equine influenza virus and the temperature-sensitive defect of the human virus.
Dependencies are inferred from the claim text.